Entry Detail



General Information

Database ID:exR0369049
RNA Name:RPL10
RNA Type:mRNA
Chromosome:chrX
Starnd:+
Coordinate:
Start Site(bp):154389955End Site(bp):154409168
External Links:ENSG00000147403



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABCD4
chr14
74285269
74303055
-
ABRACL
chr6
139028745
139043302
+
AC004832.3
chr22
30409255
30428990
+
AC006064.6
chr12
6556886
6607367
-
AC010132.3
chr7
42909273
42932174
-
AC010422.3
chr19
12643831
12648397
-
AC011455.2
chr19
38915404
38949855
-
AC048338.1
chr12
122207779
122266423
-
AC055811.2
chr17
17202649
17237185
-
ACO2
chr22
41469117
41528989
+
ACTB
chr7
5527148
5563784
-
ADAL
chr15
43330657
43354555
+
ADAR
chr1
154582057
154628013
-
ADD3
chr10
109996368
110135565
+
ADSL
chr22
40346500
40390463
+
AEN
chr15
88621337
88632281
+
AGBL5
chr2
27042364
27070622
+
AHCY
chr20
34280268
34311802
-
AK2
chr1
33007940
33080996
-
AKR7A2
chr1
19303965
19312146
-
AL022238.4
chr22
40346529
40410054
+
AL133352.1
chr10
100505628
100529881
-
AL136295.5
chr14
24147548
24166452
+
AL590764.2
chrX
71103987
71111575
-
ALAS1
chr3
52198086
52214327
+
ALDH16A1
chr19
49453225
49471050
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-6891-3p
chr6
31355228
31355248
-
hsa-miR-7847-3p
chr11
1880105
1880125
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC002550.2
chr16
19694035
19694428
-
AC060766.7
chr17
35406684
35409768
-
AC092490.1
chr12
8788253
8795789
+
AL035446.1
chr6
140845958
140852924
-
AL121992.1
chr1
15586136
15603626
-
AL132780.1
chr14
22929607
22956374
+
AL138828.1
chr6
135991936
136225751
-
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.